GT Diagnostics develops readily deployable e-platform tools that range from interactive well-being apps that can be used at home to comprehensive tools for expert use targeting the diagnosis and monitoring of dementia.
GT Diagnostics’ tools are designed to be made available through various service providers including personal advice and support systems, residential and non-residential care, and specialised dementia centres.
Genting TauRx Diagnostic Centre Sdn Bhd, a company established in Malaysia, and its wholly owned subsidiary GT Diagnostics (UK) Limited (collectively, “GT Diagnostics”, “our”) was founded as a collaboration between Genting Berhad, a Malaysian company, and TauRx Pharmaceuticals Ltd Group, with the vision to change the diagnostic landscape and market in dementia.
Our mission is to develop and provide much needed tools required for the early diagnosis and monitoring of disease progression in dementia; from tools that can be used in the comfort of one’s home to tools that require administration by experts.
GT Diagnostics develops readily deployable e-platform tools for home use as well-being apps, alongside professional tools for expert use targeting the diagnosis and monitoring of dementias. Our tools are designed to be made available through various channels and service providers, ranging from professional service providers, clinicians, residential and non-residential care centres, to specialised dementia centres.
GT Diagnostics (UK) Limited is based in Aberdeen.
Genting Berhad is embracing innovation and the adoption of new technology while TauRx Therapeutics is committed to the development of a treatment for dementia. As a result of their partnership, they have founded GT Diagnostics to develop intelligent tools to assist with early dementia detection.
Driven by the values of our founding partners, we aim to change the diagnostic landscape and market in dementia. Our mission is to provide the missing tools for early diagnosis and monitoring of disease progression in dementia; tools that can be used in the comfort of one’s home to tools that require administration by experts. These tools are designed with the aim to benefit millions who are worried about their cognitive health.
GT Diagnostics has the vision to develop novel diagnostic and monitoring tools for dementia that: